Structural Characterization of a Therapeutic Anti-Methamphetamine Antibody Fragment: Oligomerization and Binding of Active Metabolites
Eric C. Peterson(Children's Hospital of Philadelphia), Kottayil I. Varughese(University of Arkansas for Medical Sciences)
Cited by 7
Related Papers
Structure-based Design Targeted at LOX-1, a Receptor for Oxidized Low-Density Lipoprotein
|Scientific Reports|2015|48
The Development and Characterization of an scFv-Fc Fusion–Based Gene Therapy to Reduce the Psychostimulant Effects of Methamphetamine Abuse
|Journal of Pharmacology and Experimental Therapeutics|2020|28